GENETIC DISEASES, X-LINKED
Clinical trials for GENETIC DISEASES, X-LINKED explained in plain language.
Never miss a new study
Get alerted when new GENETIC DISEASES, X-LINKED trials appear
Sign up with your email to follow new studies for GENETIC DISEASES, X-LINKED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for duchenne: drug targets genetic glitch to slow muscle decline
Disease control CompletedThis study tested a drug called ataluren in 360 boys (age 5 and older) with Duchenne muscular dystrophy caused by a 'nonsense mutation' – a specific genetic typo. The goal was to see if ataluren could help them walk farther over 72 weeks compared to a placebo. All participants we…
Matched conditions: GENETIC DISEASES, X-LINKED
Phase: PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 17, 2026 01:57 UTC
-
Diabetes drug shows promise for fragile x symptoms in new trial
Symptom relief CompletedThis study tested if metformin, a common diabetes medicine, can help improve language, behavior, and weight problems in people with fragile X syndrome. 125 people aged 6 to 35 took either metformin or a placebo for 4 months. Researchers measured changes in speaking, behavior, and…
Matched conditions: GENETIC DISEASES, X-LINKED
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated May 29, 2026 14:19 UTC